The double burden: Navigating type 1 diabetes and obesity

Nele Steenackers¹, Alix Nessa Feldman², Chantal Mathieu^{1

3}, Jonathan Rosen⁴, Jeannette Soderberg⁵, Ebaa Al-Ozairi^{6

7}, Carel W le Roux⁸, Bart Van der Schueren^{1

3}

Affiliations

¹ Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, Leuven, Belgium.
² Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark.
³ Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium.
⁴ JDRF International, New York, New York, USA.
⁵ JDRF, Stockholm, Sweden.
⁶ Clinical Research Unit, Medical Division, Dasman Diabetes Institute, Kuwait City, Kuwait.
⁷ Department of Medicine, College of Medicine, Jabriya, Kuwait.
⁸ Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.

Nele Steenackers et al. Clin Obes. 2024 Jun.

. 2024 Jun;14(3):e12645.

doi: 10.1111/cob.12645. Epub 2024 Feb 9.

Nele Steenackers¹, Alix Nessa Feldman², Chantal Mathieu^{1

3}, Jonathan Rosen⁴, Jeannette Soderberg⁵, Ebaa Al-Ozairi^{6

7}, Carel W le Roux⁸, Bart Van der Schueren^{1

3}

¹ Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, Leuven, Belgium.
² Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark.
³ Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium.
⁴ JDRF International, New York, New York, USA.
⁵ JDRF, Stockholm, Sweden.
⁶ Clinical Research Unit, Medical Division, Dasman Diabetes Institute, Kuwait City, Kuwait.
⁷ Department of Medicine, College of Medicine, Jabriya, Kuwait.
⁸ Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.

No abstract available

References

1. Mathieu C, Martens PJ, Vangoitsenhoven R. One hundred years of insulin therapy. Nat Rev Endocrinol. 2021;17:715‐725. doi:10.1038/s41574‐021‐00542‐w
1. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643‐2653. doi:10.1056/NEJMoa052187
1. Charleer S, de Block C, van Huffel L, et al. Quality of life and glucose control after 1 year of Nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 Diabetes (FUTURE): a prospective observational real‐world cohort study. Diabetes Care. 2020;43:389‐397. doi:10.2337/dc19‐1610
1. Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT research group. Diabetes Care. 1988;11:567‐573. doi:10.2337/diacare.11.7.567
1. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure. JAMA. 1998;280:140‐146. doi:10.1001/jama.280.2.140